1
|
Risk of endometrial cancer after tamoxifen treatment of breast cancer.
|
Lancet
|
1994
|
4.38
|
2
|
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.
|
Int J Epidemiol
|
2000
|
2.97
|
3
|
Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research.
|
Int J Epidemiol
|
1990
|
2.69
|
4
|
A systematic review of treatment modalities for primary basal cell carcinomas.
|
Arch Dermatol
|
1999
|
2.36
|
5
|
Prognostic significance of radial margins of clearance in rectal cancer.
|
Br J Surg
|
1996
|
2.15
|
6
|
Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands.
|
Ann Oncol
|
1996
|
1.76
|
7
|
The joint association of air pollution and noise from road traffic with cardiovascular mortality in a cohort study.
|
Occup Environ Med
|
2008
|
1.63
|
8
|
Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study.
|
Ann Oncol
|
2012
|
1.49
|
9
|
Cancer mortality trends in the EU and acceding countries up to 2015.
|
Ann Oncol
|
2003
|
1.38
|
10
|
Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study.
|
Gut
|
2010
|
1.38
|
11
|
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient?
|
Eur J Cancer
|
2003
|
1.32
|
12
|
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.
|
Gut
|
2005
|
1.26
|
13
|
Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry. Coordinating Committee for Regional Cancer Registries.
|
Eur J Cancer
|
1995
|
1.12
|
14
|
Cancer in the very elderly Dutch population.
|
Cancer
|
2000
|
1.12
|
15
|
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996.
|
Eur J Cancer
|
2002
|
1.06
|
16
|
Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study.
|
Am J Epidemiol
|
2010
|
0.99
|
17
|
Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies.
|
Br J Cancer
|
2006
|
0.95
|
18
|
Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study.
|
Lung Cancer
|
2004
|
0.95
|
19
|
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.
|
Gut
|
2006
|
0.95
|
20
|
A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis.
|
Ann Oncol
|
2013
|
0.93
|
21
|
The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.
|
Br J Cancer
|
2013
|
0.93
|
22
|
Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer.
|
Br J Cancer
|
2006
|
0.92
|
23
|
Genetic susceptibility to sporadic ovarian cancer: a systematic review.
|
Biochim Biophys Acta
|
2011
|
0.91
|
24
|
Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis.
|
Br J Cancer
|
2007
|
0.91
|
25
|
Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma.
|
Br J Cancer
|
2006
|
0.87
|
26
|
A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands.
|
J Med Screen
|
2000
|
0.86
|
27
|
Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation.
|
Radiother Oncol
|
1999
|
0.84
|
28
|
The Neuro-Oncology Register.
|
Neuroepidemiology
|
1992
|
0.84
|
29
|
False-negative findings in skin cancer and melanoma screening.
|
J Am Acad Dermatol
|
1995
|
0.83
|
30
|
[Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
|
Ned Tijdschr Geneeskd
|
2000
|
0.83
|
31
|
Factors influencing participation among melanoma screening attenders.
|
Acta Derm Venereol
|
1997
|
0.82
|
32
|
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up.
|
Breast
|
2001
|
0.82
|
33
|
Mammography in the follow-up after breast-conserving treatment in cancer of the breast: suitability for mammographic interpretation, validity and interobserver variation.
|
Br J Radiol
|
1995
|
0.81
|
34
|
Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
|
Lancet
|
1997
|
0.80
|
35
|
Diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands.
|
Br J Cancer
|
2013
|
0.80
|
36
|
Validation of a database on acrylamide for use in epidemiological studies.
|
Eur J Clin Nutr
|
2010
|
0.79
|
37
|
Incidence of primary central nervous system cancers in South and East Netherlands in 1989-1994.
|
Neuroepidemiology
|
1998
|
0.79
|
38
|
Skin cancer screening focusing on melanoma yields more selective attendance.
|
Arch Dermatol
|
1995
|
0.79
|
39
|
The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer.
|
Am J Clin Oncol
|
1997
|
0.78
|
40
|
Risk factors, genetic predisposition and mutations in the VHL gene in sporadic renal cell carcinoma: The Netherlands Cohort Study.
|
IARC Sci Publ
|
2002
|
0.78
|
41
|
Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer.
|
Anticancer Res
|
2000
|
0.76
|
42
|
[Increasing incidence of mesothelioma in the future due to occupational exposure to asbestos in the past].
|
Ned Tijdschr Geneeskd
|
1997
|
0.75
|
43
|
Ascertainment corrected rates.
|
Int J Epidemiol
|
1994
|
0.75
|
44
|
A plea for better coding rules for bladder cancer.
|
Br J Cancer
|
1993
|
0.75
|
45
|
[Incidence and treatment of prostatic carcinoma in the region of the Amsterdam Comprehensive Cancer Center, 1989-1994].
|
Ned Tijdschr Geneeskd
|
1997
|
0.75
|
46
|
[Doctors are increasingly held liable for missed diagnosis of cancer in mass screening].
|
Ned Tijdschr Geneeskd
|
2001
|
0.75
|
47
|
Incidence of primary cancer of the central nervous system in southeastern Netherlands during the period 1980-94. Specialists in neuro-oncology in southeastern Netherlands.
|
Cancer Causes Control
|
1998
|
0.75
|
48
|
A phase II study with mitomycin and vindesine in metastatic pretreated breast cancer.
|
Eur J Cancer
|
1991
|
0.75
|
49
|
Prostate cancer susceptibility genes on 8p21-23 in a Dutch population.
|
Prostate Cancer Prostatic Dis
|
2013
|
0.75
|
50
|
Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases.
|
Breast Cancer Res Treat
|
1994
|
0.75
|
51
|
[Socioeconomic variations in the survival of cancer patients].
|
Ned Tijdschr Geneeskd
|
1996
|
0.75
|
52
|
Remarkable age-dependent sex differences in the incidence of adenocarcinoma of the gastric cardia and oesophagus in The Netherlands.
|
Eur J Cancer
|
1997
|
0.75
|
53
|
Total skin examination during screening for malignant melanoma does not increase the detection rate.
|
Br J Dermatol
|
1996
|
0.75
|
54
|
Volunteer melanoma screenings. Follow-up, compliance, and outcome.
|
Dermatol Surg
|
1997
|
0.75
|
55
|
A uniform histological cluster scheme for ICD-O-coded primary central nervous system tumors.
|
Neuroepidemiology
|
1998
|
0.75
|